Very Low n–3 Long-Chain Polyunsaturated Fatty Acid Status in Austrian Vegetarians and VegansKornsteiner M. · Singer I. · Elmadfa I.
Department of Nutritional Sciences, Faculty of Life Sciences, University of Vienna, Vienna, Austria
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Background/Aims: The objective of the study was to collect data on dietary fat intake of omnivores, vegetarians, vegans and semi-omnivores as well as its impact on n–3 and n–6 fatty acids in long-term markers such as sphingolipids, phosphatidylcholine (PC), phosphatidylserine (PS), phosphatidylethanolamine (PE) as well as the calculated sphingo- and phospholipids (SPL) of erythrocytes. Method: The present observational study included 98 Austrian adult volunteers of both genders, of which 23 were omnivores, 25 vegetarians, 37 vegans, and 13 semi-omnivores. Information on anthropometry using measured body weight and height was obtained. The amount and composition of ingested fat were calculated from 24-hour recalls and the fatty acid pattern in the phospholipids was assessed using gas chromatography. Results: The unbalanced n–6/n–3 ratio and the limited dietary sources of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in vegans and vegetarians led to reductions in C20:5n–3, C22:5n–3, C22:6n–3 and total n–3 fatty acids in SPL, PC, PS and PE compared with omnivores and semi-omnivores. The total content of polyunsaturated fatty acids, monounsaturated fatty acids and saturated fatty acids remained unchanged. Conclusion: The vegetarian diet, with an average n–6/n–3 ratio of 10/1, promotes biochemical n–3 tissue decline. To ensure physical, mental and neurological health vegetarians have to reduce the n–6/n–3 ratio with an additional intake of direct sources of EPA and DHA, regardless of age and gender.
© 2008 S. Karger AG, Basel
- Raatz SK, Bibus D, Thomas W, Kris-Etherton P: Total fat intake modifies plasma fatty acid composition in humans. J Nutr 2001;131:231–234.
- Harris WS, Von Schacky C: The omega–3 Index: a new risk factor for death from coronary heart disease? Prev Med 2004;39:212–220.
- Kris-Etherton PM, Harris WS, Appel LJ: Fish consumption, fish oil, omega–3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol 2003;23:e20–e30.
- Kris-Etherton P, Daniels SR, Eckel RH, Engler M, Howard BV, Krauss RM, Lichtenstein AH, Sacks F, St Jeor S, Stampfer M, Eckel RH, Grundy SM, Appel LJ, Byers T, Campos H, Cooney G, Denke MA, Howard BV, Kennedy E, Krauss RM, Kris-Etherton P, Lichtenstein AH, Marckmann P, Pearson TA, Riccardi G, Rudel LL, Rudrum M, Sacks F, Stein DT, Tracy RP, Ursin V, Vogel RA, Zock PL, Bazzarre TL, Clark J: Summary of the scientific conference on dietary fatty acids and cardiovascular health: Conference summary from the nutrition committee of the American Heart Association. Circulation 2001;103:1034–1039.
- Harper CR, Jacobson TA: Usefulness of omega–3 fatty acids and the prevention of coronary heart disease. Am J Cardiol 2005;96:1521–1529.
- Simopoulos AP: Omega–3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002;21:495–505.
- Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A: Dietary long-chain n–3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 2004;79:935–945.
Sanders TA: Essential fatty acid requirements of vegetarians in pregnancy, lacta- tion, and infancy. Am J Clin Nutr 1999;70 (suppl):555S–559S.
- Uauy R, Mena P, Rojas C: Essential fatty acids in early life: structural and functional role. Proc Nutr Soc 2000;59:3–15.
- Jump DB: The biochemistry of n–3 polyunsaturated fatty acids. J Biol Chem 2002;277:8755–8758.
- Muskiet FA, Fokkema MR, Schaafsma A, Boersma ER, Crawford MA: Is docosahexaenoic acid (DHA) essential? Lessons from DHA status regulation, our ancient diet, epidemiology and randomized controlled trials. J Nutr 2004;134:183–186.
- Wainwright PE: Dietary essential fatty acids and brain function: a developmental perspective on mechanisms. Proc Nutr Soc 2002;61:61–69.
- Burdge GC, Jones AE, Wootton SA: Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men. Br J Nutr 2002;88:355–363.
- Burdge GC, Wootton SA: Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr 2002;88:411–420.
Davis BC, Kris-Etherton PM: Achieving optimal essential fatty acid status in vegetarians: current knowledge and practical implications. Am J Clin Nutr 2003;78 (suppl):640S–646S.
- Fokkema MR, Brouwer DA, Hasperhoven MB, Hettema Y, Bemelmans WJ, Muskiet FA: Polyunsaturated fatty acid status of Dutch vegans and omnivores. Prostaglandins Leukot Essent Fatty Acids 2000;63:279–285.
- Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957;226:497–509.
- Holub BJ, Skeaff CM: Nutritional regulation of cellular phosphatidylinositol. Methods Enzymol 1987;141:234–244.
- Phinney SD, Odin RS, Johnson SB, Holman RT: Reduced arachidonate in serum phospholipids and cholesteryl esters associated with vegetarian diets in humans. Am J Clin Nutr 1990;51:385–392.
- Sanders TA, Roshanai F: Platelet phospholipid fatty acid composition and function in vegans compared with age- and sex-matched omnivore controls. Eur J Clin Nutr 1992;46:823–831.
- Li D, Ball M, Bartlett M, Sinclair A: Lipoprotein(a), essential fatty acid status and lipoprotein lipids in female Australian vegetarians. Clin Sci (Lond) 1999;97:175–181.
Sabate J: The contribution of vegetarian diets to human health. Forum Nutr 2003;56:218–220.
- Rosell MS, Lloyd-Wright Z, Appleby PN, Sanders TA, Allen NE, Key TJ: Long-chain n-3 polyunsaturated fatty acids in plasma in British meat-eating, vegetarian, and vegan men. Am J Clin Nutr 2005;82:327–334.
- Sanders TA, Ellis FR, Dickerson JW: Studies of vegans: the fatty acid composition of plasma choline phosphoglycerides, erythrocytes, adipose tissue, and breast milk, and some indicators of susceptibility to ischemic heart disease in vegans and omnivore controls. Am J Clin Nutr 1978;31:805–813.
- Agren JJ, Tormala ML, Nenonen MT, Hanninen OO: Fatty acid composition of erythrocyte, platelet, and serum lipids in strict vegans. Lipids 1995;30:365–369.
Holman RT: The slow discovery of the importance of omega 3 essential fatty acids in human health. J Nutr 1998;128(suppl):427S–433S.
- Simopoulos AP: Importance of the ratio of omega–6/omega–3 essential fatty acids: evolutionary aspects. World Rev Nutr Diet 2003;92:1–22.
National Research Council: Recommended Dietary Allowances. Food and Nutrition Board (FNB): Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids: Washington, National Academy Press, 2005.
Deutsche Gesellschaft für Ernährung, Österreichische Gesellschaft für Ernährung, Schweizerische Gesellschaft für Ernährung, Schweizerische Vereinigung für Ernährung: D-A-CH-Referenzwerte. Referenzwerte für die Nährstoffzufuhr. Heidelberg, Umschau Braus, 2000.
- Arab L: Biomarkers of fat and fatty acid intake. J Nutr 2003;133(suppl 3):925S–932S.
- Connor WE, Neuringer M, Lin DS: Dietary effects on brain fatty acid composition: the reversibility of n–3 fatty acid deficiency and turnover of docosahexaenoic acid in the brain, erythrocytes, and plasma of rhesus monkeys. J Lipid Res 1990;31:237–247.
- Bourre JM: Roles of unsaturated fatty acids (especially omega–3 fatty acids) in the brain at various ages and during ageing. J Nutr Health Aging 2004;8:163–174.
- Yehuda S, Rabinovitz S, Carasso RL, Mostofsky DI: The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiol Aging 2002;23:843–853.
- Heude B, Ducimetiere P, Berr C: Cognitive decline and fatty acid composition of erythrocyte membranes – the EVA Study. Am J Clin Nutr 2003;77:803–808.
- Sontrop J, Campbell MK: Omega–3 polyunsaturated fatty acids and depression: A review of the evidence and a methodological critique. Prev Med 2006;42:4–13.
- Ranjekar PK, Hinge A, Hegde MV, Ghate M, Kale A, Sitasawad S, Wagh, UV, Debsikdar VB, Mahadik SP: Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res 2003;121:109–122.
- Khan MM, Evans DR, Gunna V, Scheffer RE, Parikh VV, Mahadik SP: Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics. Schizophr Res 2002;58:1–10.
- Assies J, Lieverse R, Vreken P, Wanders RJ, Dingemans PM, Linszen DH: Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biol Psychiatry 2001;49:510–522.
- Chen JR, Hsu SF, Hsu CD, Hwang LH, Yang SC: Dietary patterns and blood fatty acid composition in children with attention-deficit hyperactivity disorder in Taiwan. J Nutr Biochem 2004;15:467–472.
- Vancassel S, Durand G, Barthelemy C, Lejeune B, Martineau J, Guilloteau D, Anders C, Chalon S: Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fatty Acids 2001;65:1–7.
- Appleby PN, Key TJ, Thorogood M, Burr ML, Mann J: Mortality in British vegetarians. Public Health Nutr 2002;5:29–36.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.